Could the Systemic Inflammatory Response Index be a Marker for the Non-Dipper Pattern in Newly Diagnosed Hypertensive

Mustafa Kaplangoray1, Kenan Toprak2, Cuneyt Caglayan3

  • 1Cardiology Department, Acıbadem Eskişehir Hospital, Eskişehir, Turkey. mkaplangoray@gmail.com.

Cardiovascular Toxicology
|February 24, 2025
PubMed

Insights

The Systemic Inflammatory Response Index (SIRI) can predict non-dipper hypertension (NDHT). Higher SIRI levels were found in non-dipper hypertensive patients, indicating its potential as a diagnostic marker.

Area of Science:

  • Cardiology
  • Immunology
  • Hypertension Research

Background:

  • The Systemic Inflammatory Response Index (SIRI) is linked to outcomes in cardiovascular diseases like coronary artery disease and heart failure.
  • Non-dipper hypertension (NDHT), a pattern of abnormal blood pressure dipping, is associated with increased cardiovascular risk.
  • Investigating novel biomarkers for identifying NDHT is crucial for risk stratification and management.

Purpose of the Study:

  • To evaluate the association between the Systemic Inflammatory Response Index (SIRI) and non-dipper hypertension (NDHT) in newly diagnosed hypertensive patients.
  • To determine if SIRI can serve as an independent predictor for NDHT.
  • To compare the diagnostic performance of SIRI against other inflammatory and cardiovascular risk markers for NDHT.

Main Methods:

  • A retrospective study of 254 newly diagnosed hypertensive patients who underwent ambulatory blood pressure monitoring (ABPM).
  • Patients were categorized into dipper (DHT) and non-dipper (NDHT) groups.
  • SIRI was calculated using neutrophil, monocyte, and lymphocyte counts. Other markers included MHR, NLR, PLR, CRP, HDL-C, and LVMI.

Main Results:

  • The NDHT group exhibited significantly higher SIRI, MHR, NLR, PLR, CRP, and neutrophil counts compared to the DHT group.
  • Conversely, HDL-C and lymphocyte counts were lower in the NDHT group.
  • Multivariate analysis identified SIRI, LVMI, and HDL-C as independent predictors of NDHT. SIRI demonstrated superior discriminative capacity for predicting NDHT compared to other indices.

Conclusions:

  • SIRI is an independent and significant predictor of non-dipper hypertension.
  • The Systemic Inflammatory Response Index shows superior diagnostic performance for identifying NDHT compared to MHR, NLR, PLR, HDL-C, and LVMI.
  • SIRI may serve as a valuable, easily accessible biomarker for detecting NDHT in clinical practice.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
41
Special considerations while measuring blood pressure01:28

Special considerations while measuring blood pressure

When assessing blood pressure (BP), healthcare professionals must consider various factors and potential unexpected outcomes to ensure accurate readings and provide proper patient care. Adhering to these guidelines is essential to achieving the most reliable results.
Monitoring Both Arms:
Monitoring BP in both arms during the initial assessment is advisable, as the systolic value may differ by five to ten mm Hg between arms. For subsequent BP assessments, use the arm with the higher reading.
698
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
1.9K
Measurement of Blood Pressure01:17

Measurement of Blood Pressure

Assessing blood pressure is a standard procedure executed in virtually all medical environments. The method utilized today was established over a hundred years ago by an innovative Russian doctor, Dr. Nikolai Korotkoff. The soft ticking noise, known as Korotkoff sounds, heard while taking blood pressure readings results from turbulent blood flow within the vessels. The apparatus required for this procedure includes a sphygmomanometer, a blood pressure cuff attached to a gauge, and a...
811
Assessment of blood pressure in brachial artery(one-step method)01:15

Assessment of blood pressure in brachial artery(one-step method)

This procedural guide systematically measures blood pressure using an oscillometric digital sphygmomanometer, emphasizing accuracy, patient safety, and comfort.
Prepare for the Procedure:
551
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
469